Development of vaccines and tests for SARS-CoV-2

8. For medical progress

Without preclinical testing in animals, research into new medicinal substances would thus be unethical towards the human subjects in the subsequent clinical trial phases. The rejection of research using animals therefore prevents medical progress. However, researchers also have an ethical obligation with regard to the well-being of the animals. For this reason, pharmaceutical companies and scientific institutions in Switzerland follow the 3Rs strategy. In view of the incredible medical advances of the last few years, there can be no question of forgoing animal experiments: otherwise we would not have any vaccines now against the coronavirus nor effective therapies for cardiovascular disease, various forms of cancer and other serious diseases.